p53: emergency brake and target for cancer therapy.
Wiman
K G
KG
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden. Klas.Wiman@mtc.ki.se
D000818:Animals; D017209:Apoptosis; D002453:Cell Cycle; D002455:Cell Division; D004268:DNA-Binding Proteins / Q000235:genetics; D016147:Genes, Tumor Suppressor; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D009687:Nuclear Proteins / Q000235:genetics; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D025521:Tumor Suppressor Proteins
D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins